Mosquirix, the first malaria vaccine to be submitted for regulatory approval, has gained the support of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Although the CHMP was established to assess the quality, safety and efficacy of medicinal products to be used in the EU, it can also help facilitate the introduction of new medicines to non-EU countries. Following a rigorous assessment of the safety and efficacy of Mosquirix, in consultation with experts from the World Health Organization (WHO), the CHMP considers that the benefits of the vaccine outweigh the risk when used in children living in areas with high malaria risk.
Mosquirix is intended to be used to immunize children aged 6 weeks to 17 months in areas where malaria caused by the Plasmodium falciparum parasite is prevalent. Since Mosquirix is a recombinant vaccine composed of a protein from the Plasmodium falciparum fused with hepatitis B surface antigen, it also provides protection against hepatitis B.Malaria is a disease transmitted through bites from mosquitoes infected with plasmodia parasites.Plasmodium falciparum causes the most serious form of malaria.
If left untreated, this type of malaria can quickly become fatal. The WHO reported that in 2013 90% of deaths from malaria worldwide occurred in Africa and were mostly of children under the age of 5 years.
The main evidence for the new vaccine was obtained from a large clinical trial conducted in seven African countries (Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania). Mosquirix was shown to effectively prevent malaria in just over half of children aged between 5-17 months and less than a third of children aged 6-12 weeks. The level of protection afforded by the vaccine decreased a year after vaccination.
Mosquirix does not therefore provide full immunity from developing malaria and the protection it does provide decreases over time. Consequently, continued use of mosquito nets impregnated with insect repellent and other established protective measures will be needed.
However, the CHMP decided that despite these limitations any reduction in risk would be beneficial for children living in areas where malaria mortality rates are high.
ReplyDeleteAfter being in relationship with Wilson for seven years,he broke up with me, I did everything possible to bring him back but all was in vain, I wanted him back so much because of the love I have for him, I begged him with everything, I made promises but he refused. I explained my problem to someone online and she suggested that I should contact a spell caster that could help me cast a spell to bring him back but I am the type that don't believed in spell, I had no choice than to try it, I meant a spell caster called Dr Zuma zuk and I email him, and he told me there was no problem that everything will be okay before three days, that my ex will return to me before three days, he cast the spell and surprisingly in the second day, it was around 4pm. My ex called me, I was so surprised, I answered the call and all he said was that he was so sorry for everything that happened, that he wanted me to return to him, that he loves me so much. I was so happy and went to him, that was how we started living together happily again. Since then, I have made promise that anybody I know that have a relationship problem, I would be of help to such person by referring him or her to the only real and powerful spell caster who helped me with my own problem and who is different from all the fake ones out there. Anybody could need the help of the spell caster, his email: spiritualherbalisthealing@gmail.com or call him +2348164728160 you can email him if you need his assistance in your relationship or anything. CONTACT HIM NOW FOR SOLUTION TO ALL YOUR PROBLEMS